Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have atrial fibrillation (an irregular heartbeat), either the type that comes and goes (paroxysmal) or the type that has lasted a while but can still be treated (persistent)
- People whose doctor has recommended a procedure to reset their heart rhythm, either using a catheter (a thin tube guided to the heart) or an electrical shock to restore normal rhythm
- People who have given their written agreement to take part in the trial
Who may not be able to join:
- People whose atrial fibrillation has been long-term or considered permanent
- People with a severe problem with one of the valves in their heart (the mitral valve leaking badly)
- People who have long-term heart failure where the heart's pumping strength is permanently reduced
- People who have had a stroke caused by reduced blood flow to the brain within the last 3 months
- People with severe damage or reduced function of the kidneys
- People with serious kidney insufficiency (confirm with trial site, as this and the above kidney criterion may refer to different conditions)
- People with serious liver problems that would affect blood test results used in the trial
- People who have had a heart attack within the last 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jiří Plášek, MD,PhD,FESC, University Hospital Ostrava
Phone: 0042059737
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Atrial fibrillation recurrence based on secretoneurin levels
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.